Skip to main content
Anatoly Dritschilo, MD, Radiation Oncology, Washington, DC, MedStar Georgetown University Hospital

AnatolyDritschiloMDFACR

Radiation Oncology Washington, DC

Breast Cancer, Head & Neck, Skin Cancer

Professor of Medicine, Georgetown University

Dr. Dritschilo is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Dritschilo's full profile

Already have an account?

Education & Training

  • Tufts Medical Center
    Tufts Medical CenterResidency, Radiation Oncology, 1977 - 1977
  • Brigham and Women's Hospital/Joint Center for Radiation Therapy
    Brigham and Women's Hospital/Joint Center for Radiation TherapyResidency, Radiation Oncology, 1974 - 1977
  • University of Cincinnati Medical Center Inc.
    University of Cincinnati Medical Center Inc.Internship, Transitional Year, 1973 - 1974
  • Rutgers New Jersey Medical School
    Rutgers New Jersey Medical SchoolClass of 1973

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1980 - 2024
  • DC State Medical License
    DC State Medical License 1979 - 2024
  • VA State Medical License
    VA State Medical License 1997 - 2018
  • American Board of Radiology Therapeutic Radiology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2009-2014
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Top Doctors:Washington DC Area Castle Connolly, 2012
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Shuttle Pharmaceuticals Provides First Quarter 2023 Corporate Update
    Shuttle Pharmaceuticals Provides First Quarter 2023 Corporate UpdateMay 26th, 2023
  • Shuttle Pharmaceuticals Enters Research Agreement with Georgetown University for Testing of Small Molecule Radiation Sensitizers and Immune Activation Candidates
    Shuttle Pharmaceuticals Enters Research Agreement with Georgetown University for Testing of Small Molecule Radiation Sensitizers and Immune Activation CandidatesMarch 22nd, 2023
  • Shuttle Pharmaceuticals Provides Fiscal Year 2022 Corporate Update
    Shuttle Pharmaceuticals Provides Fiscal Year 2022 Corporate UpdateMarch 15th, 2023
  • Join now to see all

Grant Support

  • Mechanisms Of Cellular Responses To Ionizing RadiationNational Cancer Institute1997–2006
  • Cancer Center Support GrantNational Cancer Institute2005
  • Georgetown University AP4 Center PLANNational Cancer Institute2004
  • Radiosensitization Of Pancreatic Cancers Through RAF-1National Cancer Institute2002
  • Molecular Studies Of Radiation Resistant Tumor CellsNational Cancer Institute1997–2001
  • ATM Gene In Breast Cancer--Prospective Clinical TrialNational Cancer Institute1997–2001
  • Molecular Studies Of Radiation Resistant Tumor CellsNational Cancer Institute1987–2000
  • Oligonucleotide Manipulation--Tumor Cell RadioresistanceNational Cancer Institute1994
  • Radiation Resistance And Adp-Ribose MetabolismNational Cancer Institute1992–1994
  • Molecular Basis Of Tumor Resistance To Ionize RadiationNational Cancer Institute1990–1992
  • Characterization Of Differential Gene Expression In Resistant CellsNational Cancer Institute1990–1992

Professional Memberships

Hospital Affiliations